[Somatostatin for the treatment of a post-oesophagectomy chylothorax]

Ann Fr Anesth Reanim. 2004 Feb;23(1):56-8. doi: 10.1016/j.annfar.2003.10.010.
[Article in French]

Abstract

Chylothorax is a rare but serious complication after oesophagectomy procedure. We report the case of a 59-year-old man who underwent an oesophagectomy by Akiyama procedure. A persistent postoperative chylothorax occurred requiring drainage and conservative management. After one week, the failure of this management motivated the institution of continuous infusion of somatostatin. This led to a rapid cessation of chyle production without side effect and to the discharge of the patient from the intensive care unit.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Chylothorax / drug therapy*
  • Chylothorax / etiology*
  • Chylothorax / therapy
  • Drainage
  • Esophagectomy / adverse effects*
  • Hormone Antagonists / administration & dosage
  • Hormone Antagonists / adverse effects
  • Hormone Antagonists / therapeutic use*
  • Humans
  • Infusions, Intravenous
  • Male
  • Middle Aged
  • Postoperative Complications / drug therapy*
  • Postoperative Complications / therapy
  • Somatostatin / administration & dosage
  • Somatostatin / adverse effects
  • Somatostatin / therapeutic use*

Substances

  • Hormone Antagonists
  • Somatostatin